|
A
|
Adjustment for Confounders |
| ADR |
Adverse drug reaction |
| AIC |
Akaike information criterion |
|
B
|
Blinding |
| BIC |
Bayesian information criterion |
|
D
|
Duration |
|
DR
|
Dose-response Relationship |
| ECETOC |
European Centre for Ecotoxicology and Toxicology of Chemicals |
|
ES
|
Effect Size |
| EUDRAVIGILANCE |
European Union Drug Regulating Authorities Pharmacovigilance |
| FAERS |
FDA Adverse Event Reporting System |
| FDA |
Food and Drug Administration (US) |
| IC |
Information Component |
|
M
|
Mechanistic Knowledge |
| MCP-Mod |
Multiple Comparison Procedures and Modeling algorithm |
| MGPS |
Multi-item Gamma Poisson Shrinker |
|
PD
|
Probabilistic Dependence |
| PRR |
Proportional Reporting Ratio |
|
R
|
Randomisation |
| RCT |
Randomized controlled trial |
|
REP
|
Report Variable |
|
RoG
|
Rate of Growth |
| ROR |
Reporting Odds Ratio |
|
SB
|
Sponsorship Bias |
|
SS
|
Sample Size |
|
T
|
Temporal Precedence |
| WHO |
World Health Organization |
|
©
|
Hypothesis of Causation |
| Δ |
Difference Making |
|
|
Available Evidence |
| Σ |
Set of statistical Indicators: PD, DR and RoG
|